← Back
Research Paper Volume 14, Issue 6 pp 2868—2879

TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types

class="figure-viewer-img"

Figure 4. (A) Gene ontology (GO) and (B) Kyoto encyclopedia of gene and genomes (KEGG) pathway analysis of different expression mRNAs between TP53MUTBRAFWT and BRAFMUTTP53WT.